Korean Market
OWNR
BIODYNE
★

CEO Ukbin Im Boosts Stake to 40.65% via Open Market Purchases, Positive Signal for Share Price

 
OWNR
BIODYNE
★

Large Shareholding Report Filed (No Specific Changes Disclosed)

 
EXCH
BIODYNE
★

Investor Relations Meeting: NDR for Domestic Institutional Investors on May 27-28, 2026

 
PERI
BIODYNE
★

Biodyne Q1 2026: Net Profit Turns Positive, Operating Loss Continues